お問い合わせフォーム
に入力の上、ご送信ください。詳細は折り返しメールでお伺いしますので簡単で結構です。
構造式をクリックして表示される詳細画面からでもお問い合わせいただけます。
| SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
|---|---|---|---|---|---|
| 06410 |  | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >95% | 0.4 |
| 06064 |  | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05373 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 133,000/0.1mg | >90% | 0.1 |
| 05078 |  | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0 |
| 04731 |  | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 |
| 04727 |  | Cy3-CONH-PEG13-COOH | 68,800/0.1mg | >95% | 0.1 |
| 04726 |  | Cy5(1-Hex-CONH-PEG13-COOH 8,8-diMe 1'-Me 8',8'-diMe) | 69100/<0.1mg | >90% | 0.1 |
| 04721 |  | Cy3-CONH-PEG13-COOtBu | 66,600/0.1mg | >95% | 0.1 |
| 04720 |  | Cy5(1-Hex-CONH-PEG13-COOtBu 8,8-diMe 1'-Me 8',8'-diMe) | 66,600/0.1mg | >90% | 1.5 |
| 06479 |  | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 68,800/0.1mg | >90% | 0.4 |
| 06518 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 68,800/0.1mg | >90% | 0 |
| 06402 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 06516 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06432 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06417 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06426 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06419 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06895 |  | Cy5(1,1'-PEG4 8,8-diMe 8',8'-diMe) | 66,300/2.5mg | >95% | 2.2 |
| 06511 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06509 |  | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06434 |  | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06433 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 68,800/0.1mg | >90% | 0 |
| 06422 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06409 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 133,000/0.1mg | >95% | 0 |
| 06062 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 06009 |  | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0 |
| 05970 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 00207 |  | Cy3-CONH-PEG4-O-Et-CONHPrCOOH | 65,700/0.4mg | >95% | 44.6 |
| 06512 |  | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 68,800/0.1mg | >90% | 0 |
| 06431 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06430 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06425 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06423 |  | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06421 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06420 |  | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06061 |  | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >95% | 0.1 |
| 01331 |  | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0 |
| 06515 |  | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06513 |  | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06510 |  | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0 |
| 06440 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06439 |  | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >90% | 0 |
| 06843 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOAc 8',8'-diMe) | 63,400/0.2mg | >95% | 1.9 |
| 06840 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOH 8',8'-diMe) | 65,700/0.4mg | >95% | 0.7 |
| 06523 |  | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06522 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 68,800/0.1mg | >95% | 0 |
| 06521 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06520 |  | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >90% | 0 |
| 06519 |  | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06517 |  | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 133,000/0.1mg | >95% | 0 |
| 06514 |  | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06477 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-AcOtBu 8',8'-diMe) | 133,000/0.1mg | >90% | 1.1 |
| 06446 |  | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 68,800/0.1mg | >95% | 0 |
| 06438 |  | Cy7(1-HexCOOH 8,8-diMe 1'-Me 8',8'-diMe)(3,5-Pr-cyclic) | 133,000/0.1mg | >95% | 0 |
| 06418 |  | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 68,800/0.1mg | >95% | 0 |
| 06416 |  | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 68,800/0.1mg | >95% | 0 |
| 06296 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 105,500/0.1mg | >90% | 0.9 |
| 05955 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 68,800/0.2mg | >90% | 0.1 |
| 05940 |  | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 64,000/0.7mg | >90% | 0.5 |
| 05393 |  | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 68,800/0.1mg | >95% | 0.1 |
| 05148 |  | Sulfo-Cy3 bis(IAA) | 68,800/0.2mg | >95% | 0.1 |
| 05147 |  | Sulfo Cy3-diamine | 68,800/0.2mg | >95% | 5.0 |
| 05143 |  | Sulfo-Cy3 | 65,700/0.4mg | >95% | 2.6 |
| 05130 |  | Suflo-Cy3 | 64,000/0.7mg | >95% | 4.7 |
| 04910 |  | Mono-6-NH-Cy3-beta-cyclodextrin(maleimide-conjugation) | 105,500/0.1mg | <80% | 0.1 |
| 04162 |  | Mono-6-Cy3-NH-beta-cyclodextrin(amide-conjugation) | inquire | <80% | 0.1 |
| 01980 |  | Cy3-halolinker | 63,400/0.2mg | >95% | 0.1 |
